Dynavax Technologies reported $174.24M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adma Biologics ADMA:US $ 18.88M 6.75M
Agenus AGEN:US $ 18.99M 17.71M
Amgen AMGN:US $ 5327M 250M
Astrazeneca AZN:US 9.61B 562M
AstraZeneca AZN:LN 9.61B 562M
Biogen BIIB:US $ 2003.5M 17.9M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Dynavax Technologies DVAX:US $ 174.24M 37.31M
Gilead Sciences GILD:US $ 4118M 331M
Glaxosmithkline GSK:US $ 6870M 1927M
Nektar Therapeutics NKTR:US $ 10.01M 20.21M
Neurocrine Biosciences NBIX:US $ 279M 15.5M
Novartis NOVN:VX 8.91B 232M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sarepta Therapeutics SRPT:US $ 230.28M 33.07M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M